Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KZR | AMGN | BMY | GILD | VRTX |
| Company | Kezar Life Sciences Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 6.01 | 324.13 | 60.95 | 117.00 | 483.39 |
| High | 6.21 | 335.88 | 63.16 | 119.96 | 503.89 |
| Low | 5.76 | 322.77 | 60.72 | 116.78 | 480.38 |
| Last | 5.76 | 327.36 | 63.11 | 117.21 | 500.01 |
| Change | -0.34 | +2.50 | +2.02 | -0.20 | +11.72 |
| % Change | -5.57% | +0.77% | +3.31% | -0.17% | +2.40% |
| Volume | 13,900 | 4,120,700 | 20,295,700 | 11,194,400 | 1,796,700 |
| 20-Day Average Volume | 31,175 | 3,086,835 | 12,528,990 | 9,761,710 | 1,371,225 |
| Previous Close | 6.10 | 324.86 | 61.09 | 117.41 | 488.29 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.98 | 305.89 | 57.70 | 109.70 | 476.45 |
| 20-Day Raw Stochastic | 23.58% | 82.07% | 99.48% | 89.17% | 93.30% |
| 20-Day Relative Strength | 41.64% | 70.78% | 66.91% | 75.38% | 64.97% |
| Weighted Alpha | -45.32 | +21.61 | +31.15 | +74.02 | +22.10 |
| Today's Opinion | 88% Sell | 24% Buy | 100% Buy | 100% Buy | 40% Buy |
| Previous Opinion | 72% Sell | 24% Buy | 88% Buy | 100% Buy | 40% Buy |
| Last Month's Opinion | 80% Sell | 24% Sell | 72% Buy | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.05% since 03/03/25 | +5.33% since 03/03/25 | +5.41% since 03/03/25 | +1.05% since 03/03/25 | +3.46% since 03/03/25 |
| Low | 5.51 on 03/04/25 | 310.14 on 03/05/25 | 59.03 on 03/06/25 | 113.58 on 03/04/25 | 479.78 on 03/06/25 |
| High | 6.21 on 03/10/25 | 335.88 on 03/10/25 | 63.16 on 03/10/25 | 119.96 on 03/10/25 | 503.89 on 03/10/25 |
| 1-Month | |||||
| %Chg | -5.26% since 02/10/25 | +11.05% since 02/10/25 | +13.65% since 02/10/25 | +22.76% since 02/10/25 | +6.39% since 02/10/25 |
| Low | 5.51 on 03/04/25 | 288.36 on 02/11/25 | 53.54 on 02/18/25 | 95.03 on 02/11/25 | 446.00 on 02/12/25 |
| High | 6.57 on 02/19/25 | 335.88 on 03/10/25 | 63.16 on 03/10/25 | 119.96 on 03/10/25 | 503.89 on 03/10/25 |
| 3-Month | |||||
| %Chg | -17.12% since 12/10/24 | +18.72% since 12/10/24 | +8.59% since 12/10/24 | +26.93% since 12/10/24 | +6.56% since 12/10/24 |
| Low | 5.51 on 03/04/25 | 253.30 on 12/19/24 | 53.54 on 02/18/25 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 7.04 on 12/12/24 | 335.88 on 03/10/25 | 63.16 on 03/10/25 | 119.96 on 03/10/25 | 503.89 on 03/10/25 |
| 6-Month | |||||
| %Chg | +2.86% since 09/10/24 | -0.48% since 09/10/24 | +28.06% since 09/10/24 | +43.92% since 09/10/24 | +6.21% since 09/10/24 |
| Low | 5.20 on 09/26/24 | 253.30 on 12/19/24 | 47.76 on 09/12/24 | 79.64 on 09/11/24 | 377.85 on 12/19/24 |
| High | 9.18 on 10/09/24 | 339.17 on 09/23/24 | 63.16 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 44,507 | 174,516,416 | 123,970,672 | 146,216,064 | 125,388,000 |
| Shares Outstanding, K | 7,296 | 537,205 | 2,029,312 | 1,245,346 | 256,790 |
| Annual Sales | 7,000,000 | 33,424,000,000 | 48,300,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -101,870,000 | 4,090,000,000 | -8,948,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 9,086,000,000 | 12,342,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -20,310,000 | 627,000,000 | 72,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 0.49 | 0.53 | 0.43 | 0.21 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.78 on 11/12/24 | 5.31 on 02/04/25 | 1.67 on 02/06/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 03/13/25 | 05/01/25 | 04/24/25 | 04/24/25 | 02/10/25 |
| Most Recent Dividend | N/A | 2.380 on 02/14/25 | 0.620 on 01/03/25 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/25 | 04/04/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.04 | 52.79 | 25.17 | 0.00 |